Kerry Launches 2026 Supplements Taste Charts: Defining the Next Era of Flavour in Supplements and Sports Nutrition
SINGAPORE, Jan. 16, 2026 /PRNewswire/ -- Kerry, a global leader in taste and nutrition, has released its 2026 Supplements Taste Charts for Asia Pacific and the Middle East, highlighting the region's evolving taste preferences and the rise of flavour‑forward, lifestyle‑led supplements and sports nutrition. Consumers are moving...
The AKG and Ca-AKG of Xin Tianhe have passed the US Self-GRAS certification
SHENZHEN, China, Jan. 16, 2026 /PRNewswire/ -- On January 7, 2026, the AKG and Ca-AKG of Xin Tianhe Biotechnology successfully completed the Self-GRAS scientific evaluation in accordance with the US FDA GRAS standards and were approved and became the first domestic fermentation products that obtain the GRAS authoritative certification, and obtained the qualification for entering the US market, marking...
Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
SHANGHAI and HONG KONG, Jan. 16, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that it recently presented at the 44th Annual J.P. Morgan Healthcare Conference held in San Francisco. At the...
Hugel accelerates global value creation with U.S.-led growth strategy
- President and Global CEO Carrie Strom outlines mid-term growth strategy including global vision, U.S. channel strategy, and portfolio expansion- Hugel targets KRW900 billion in total net sales and 30% of sales from U.S. by 2028 SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- Hugel, Inc., a leading global medical aesthetics company publicly...
Kelun-Biotech Showcases Innovative Achievements and Future Development Strategy at the 44th Annual JPM Healthcare Conference
CHENGDU, China, Jan. 16, 2026 /PRNewswire/ -- From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and CEO of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK), was invited to attend the conference and delivered...
SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting
HIGHLIGHTS Following an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review Committee (SRC) confirms the trial will continue with no modifications to the protocol. Patient population With the SECuRE trial continuing to recruit, a total of nine participants who had...
Recognition beyond borders: the life-long commitment of “Grandpa Sugar Pill”
BEIJING, Jan. 15, 2026 /PRNewswire/ -- A news report from China.org.cn on Gu Fangzhou, the father of sugar pills — a live oral polio vaccine:  Recognition beyond borders: the life-long commitment of "Grandpa Sugar Pill" Small, sweet, and slightly gritty when dissolved on the tongue — in the childhood memory of many Chinese lies such a tiny "sugar pill." But...
Aphranel Convenes Cadaver Dissection Class in Thailand Successfully
BANGKOK, Jan. 14, 2026 /PRNewswire/ -- The inaugural "Moyom Biotech • Aphranel Global Expert Advisory Panel • Thailand Anatomy Exchange Conference" was successfully convened in Thailand. This high-level forum gathered leading experts from multiple Asia-Pacific countries. Through this concentrated academic dialogue, Aphranel reaffirmed to the industry a clear guiding principle: to return aesthetic medicine to its medical foundation and to...
Ericsson announces proposed headcount reduction in Sweden
STOCKHOLM, Jan. 15, 2026 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announces proposed staff reductions in Sweden as part of measures aimed at ensuring the Company's competitive position. The proposed staff reduction is part of global initiatives to improve cost position while maintaining investments critical to Ericsson's technology leadership and the execution of the strategy to deliver high-performing, programmable networks...
MediCapture Launches aiScope™ Pilot for Veterinary Sciences at VMX 2026
Medical AI Made Easy—From Lab to Real-World Training & Practical Use CHEROKEE, Texas, Jan. 15, 2026 /PRNewswire/ -- MediCapture Inc., a global leader in medical imaging systems, today announced the launch of aiScope™, software that runs Vision AI models in real-time, locally on MediCapture's MTRs and selected MVR imaging systems....
